Tradestie Institutional Equity Comparison Engine
DCTH vs PMI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DCTH trades at 70.3x Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, DCTH sits in BREAKOUT (29th %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DCTH
DCTH 70.3x vs PMI N/M Fwd P/E
Growth & Margin Winner
DCTH
Op Margin 5.2% vs -248.1% ยท YoY +70.7% vs +38.6%
Momentum & Technical Winner
DCTH
1Y +122.4% vs +107.2% ยท 52W Pos 77% vs 34%
Options & Structure Winner
DCTH
BREAKOUT (29th %ile IV) vs UNCLASSIFIED (N/A IV)
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.24
-2.34% 1D
Market Cap
$685.3M
1M Return
+30.88%
1Y Return
+122.43%
Forward P/E
70.3x
Unified AI Score
35.4 / 100
SELL
Tech 50.0
Fund 36.0
Flow 73.0
Mom 44.0
PMI
NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap
$17.1M
1M Return
-34.58%
1Y Return
+107.24%
Forward P/E
N/M
Unified AI Score
48.4 / 100
HOLD
Tech 39.0
Fund 45.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DCTH +122.43%
PMI +107.24%
Spread: +25.6 pp (PMI Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DCTH Revenue | PMI Revenue | DCTH Op. Margin | PMI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2013 | $0M | N/A | -4179.6% | N/A | DCTH |
| FY2014 | $0M | N/A | -1805.8% | N/A | DCTH |
| FY2015 | $0M | N/A | -870.6% | N/A | DCTH |
| FY2021 | $0M | N/A | -690.0% | N/A | DCTH |
| FY2022 | $0M | N/A | -1245.1% | N/A | DCTH |
| FY2023 | $0M | N/A | -1849.0% | N/A | DCTH |
| FY2024 | $40M | $0M | -33.4% | -312.3% | DCTH |
| FY2025 | $90M | $0M | 0.8% | -268.4% | DCTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DCTH | PMI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $685.3M | $17.1M | Larger Scale | DCTH |
| Trailing P/E Ratio Valuation | 123.1x | 2.9x | Lower Multiple | PMI |
| Forward P/E Ratio Valuation | 70.3x | N/M | Lower Multiple | DCTH |
| Revenue Growth (YoY) Growth | +70.7% | +38.6% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | 5.2% | -248.1% | Higher Margin | DCTH |
| Net Profit Margin Profitability | 6.0% | 0.0% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | 5.4% | 0.0% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 77% ($8โ$23) | 34% ($0โ$18) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 1.64ฮฒ ยท 130% Vol | 54.06ฮฒ ยท 134% Vol | Lower Realized Risk | DCTH |
| Unified Institutional Score Composite Signal | 35.4 / 100 (SELL) | 48.4 / 100 (HOLD) | Higher Composite | PMI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DCTH vs PMI Buy Guide
DCTH
BREAKOUT
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
29th %ile
IV Regime
Balanced (25thโ60th %ile)
PMI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DCTH nor PMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.